CCI gives nod to 2 per cent acquisition of API Holdings by CDPQ Private Equity Asia
Published: Feb 23, 2021
By TIOLCORPLAWS News Service
NEW DELHI, FEB 23, 2021: THE Competition Commission of India (CCI) on Tuesday said it has cleared the proposed acquisition of approximately 2 per cent shareholding by CDPQ Private Equity Asia in API Holdings.
API Holdings is the parent entity of the API Holdings Group which is involved in the wholesale distribution and transportation of drugs and medical devices, along with managing an e-pharmacy business, Pharmeasy.
The combination envisages an acquisition of approximately 2 per cent shareholding in the API Holdings by CDPQ Private Equity Asia, along with certain additional rights, said the fair trade regulator.
CDPQ Private Equity Asia is an institutional investor that is present in India through its subsidiary CDPQ India who activities consist of providing advisory services to CDPQ Asia-Pacific. The CDPQ group is an institutional investor that manages funds primarily for public and para-public pension and insurance plans.